Naples, Italy: The administration of the nonpsychotropic cannabinoid cannabigerol (CBG) mitigates colitis (inflammation of the large intestine) in a preclinical model and ought to be assessed in clinical trials, according to data published online in the journal Biochemical Pharmacology.

Dr. David Allen discusses how the rules of engagement in the 'war on drugs' are being violated by the U.S. government, and how the body of science that now uses cannabinoid-based medicines should be used throughout America as well, not just in emergency rooms and through prescriptions, but through the ingestion of the whole plant, daily, as a supplement to their diet.

As many as eight out of every 10 of those with Parkinson’s disease suffer from inexplicable pains that until now have been left untreated because they were thought to be an inevitable part of the progressive and eventually fatal neurological disease. Parkinson’s, a brain disorder that leads to tremors and difficulty with walking, coordination and movement, usually develops after age 50 and is one of the most common nervous system disorders of the elderly.

Bill Would Remove Marijuana from Schedule I and Halt Federal Government Interference With State Medical Marijuana Regulation

WASHINGTON, D.C.—Yesterday, Rep. Earl Blumenauer (D-OR) introduced legislation that would recognize the medicinal use of marijuana and remove marijuana from Schedule I of the Controlled Substances Act.

(GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB:NVLX), international biotechnology and clinical stage provider of natural products and cell and gene therapy solutions for the treatment of human diseases, announced today its subsidiary, Medical Marijuana Sciences, Inc., is focusing on developing treatments for brain cancers, including glioblastoma multiforme, that are based on cannabinoids.